Skip to main content

Table 2 Patient-reported outcomes, cost-effectiveness and their assessment*

From: Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial

Construct

Scale acronym

Items

T 0

T 6

T 12

T 24

Health status (generic)

SF-12

12

X

X

X

X

Health status (HF specific)

KCCQ

12

X

X

X

X

Depression

PHQ-9

9

X

X

X

X

Anxiety

GAD-7

7

X

X

X

X

Expectations to ICD treatment

EXPECT-ICD

10

X

   

Expectations to use of platform/app

EXPECT-APP

6

X

   

Experience with use of platform/app

EXPERIENCE-APP

9

 

X

X

 

ICD patient concerns

ICDC

8

X

X

X

X

ICD empowerment

ICD-EMPOWER

14

X

X

X

X

Illness perceptions

B-IPQ

9 + 1

X

   

Adherence

MMAS-8

8

X

X

X

X

Type D personality

DS14

14

X

   

Device acceptance

FPAS

18

X

X

X

X

Loneliness

UCLA

3

X

X

X

X

Cost of intervention program

€

Registry

X

X

X

X

Healthcare cost during observation period

€

Registry

X

X

X

X

Labour market absence

€

Registry

X

X

 X

X

All-cause and cardiac-related mortality

Deaths

Registry

X

X

X

X

QALY

EQ-5D-5 L + VAS

6

X

X

X

X

Cost-effectiveness/utility (ICER)

€/QALY

–

X

X

X

X

Net-monetary benefit from health care and social perspective

€

-

X

X

X

X

  1. T0 = Baseline; T6 = 6 months; T12 = 12 months; T24 = 24 months
  2. *Both patients in the treatment group and usual care group will complete all measures at T0,T6,T12, and T24
  3. B-IPQ Brief Illness Perceptions Questionnaire, DS14 Type D Scale, EQ-5D-5 L EuroQoL, EXPECT-ICD Expectations to ICD treatment questionnaire, EXPECT-APP Expectations towards use of app, EXPERIENCE-APP Experience with use of app, FPAS Florida Patient Acceptance Survey, GAD Generalised Anxiety Disorder scale, ICD-EMPOWER ICD Empowerment Scale, ICDC ICD Patients’ Concerns Questionnaire, KCCQ Kansas City Cardiomyopathy Questionnaire, MMAS-8 Morisky Medication Adherence Scale, PHQ-9 Patient Health Questionnaire, QALY quality adjusted life year, SF-12 Short Form Health Survey, UCLA UCLA Loneliness Scale, VAS visual analogue scale